Aurora Cannabis Inc. (ACB)
Automate Your Wheel Strategy on ACB
With Tiblio's Option Bot, you can configure your own wheel strategy including ACB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ACB
- Rev/Share 6.4714
- Book/Share 10.7799
- PB 0.5731
- Debt/Equity 0.1841
- CurrentRatio 2.9659
- ROIC 0.1006
- MktCap 327671741.0824
- FreeCF/Share -0.0182
- PFCF -327.9997
- PE 4.5115
- Debt/Assets 0.1213
- DivYield 0
- ROE 0.1262
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 3
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ACB | TD Cowen | -- | Buy | -- | -- | Dec. 11, 2024 |
News
3 Marijuana Stocks To Watch In 2026
Published: December 26, 2025 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. After years of regulatory uncertainty, capital constraints, and volatile price action, relief is being shown. The legal cannabis market is showing clear signs of structural improvement driven by policy reform, consolidation, and expanding global demand.
Read More
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Published: December 22, 2025 by: MarijuanaStocks
Sentiment: Positive
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling fundamentally changes how the plant is viewed under federal law. With meaningful implications for operators, investors, and public markets. For the cannabis industry, the most immediate impact is financial. A shift to Schedule III would effectively eradicate IRS Section 280E. This is a law that currently prevents cannabis businesses from deducting standard operating expenses.
Read More
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
Published: December 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff highlights how fragile sentiment in cannabis stock remains, even amid policy progress. Further volatility is possible if regulatory implementation drags on or if broader market risk appetite weakens.
Read More
Trump signs executive order to reschedule cannabis. Here's what's next
Published: December 19, 2025 by: CNBC Television
Sentiment: Positive
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted the President's stance on the drug.
Read More
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
Published: December 19, 2025 by: New York Post
Sentiment: Positive
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government.
Read More
Trump sparks market shock with MAJOR marijuana move
Published: December 19, 2025 by: Fox Business
Sentiment: Negative
Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's push to sell unused federal buildings.
Read More
Trump signs executive order to reschedule marijuana, expand access to CBD products
Published: December 18, 2025 by: Proactive Investors
Sentiment: Positive
President Donald Trump on Thursday signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III, potentially easing regulatory and financial constraints for cannabis companies while keeping recreational use illegal under federal law. The order instructs the attorney general to expedite the ongoing process of rescheduling marijuana, which is currently classified alongside heroin and LSD as a Schedule I drug — considered to have a high potential for abuse and no accepted medical use.
Read More
President Trump signs executive order to reclassify marijuana, easing federal restrictions
Published: December 18, 2025 by: CNBC Television
Sentiment: Positive
President Trump signs an executive order to reclassify marijuana to a Schedule III classification, easing federal restrictions.
Read More
Trump Signs Order Easing Federal Restrictions on Marijuana
Published: December 18, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
President Donald Trump signs an executive order directing his administration to move cannabis into a less restrictive federal category. Sign up for the Washington Edition newsletter to find out how the worlds of money and politics intersect in the US capital: https://bloom.bg/3KkEimO -------- More on Bloomberg Television and Markets Like this video?
Read More
Trump signs executive order easing federal restrictions on marijuana
Published: December 18, 2025 by: Business Insider
Sentiment: Positive
Trump signed an executive order that will reclassify marijuana as a less harmful drug. The order is aimed at making it easier to research the drug.
Read More
Trump signs executive order reclassifying pot, opening door to broader access
Published: December 18, 2025 by: CNBC
Sentiment: Positive
President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.
Read More
Trump moves to ease cannabis restrictions - what does it mean for consumers?
Published: December 18, 2025 by: Reuters
Sentiment: Positive
U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here's a look at what that would mean for people shopping at dispensaries across the country.
Read More
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Published: December 18, 2025 by: Reuters
Sentiment: Positive
Shares of cannabis firms rose in premarket trading on Thursday, driven by expectations that U.S. President Donald Trump will sign an executive order easing federal regulations on marijuana.
Read More
Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?
Published: December 17, 2025 by: Fast Company
Sentiment: Positive
Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana.
Read More
Best Canadian Cannabis Stocks to Watch This Week for Traders and Investors
Published: December 16, 2025 by: MarijuanaStocks
Sentiment: Positive
Canadian cannabis stocks remain in focus this week as sector sentiment continues improving. Several Canadian operators maintain meaningful exposure to the U.S. market through brands and partnerships. Meanwhile, the U.S. cannabis industry continues expanding despite regulatory delays. Total U.S. cannabis sales now exceed $32 billion annually. Importantly, analysts project the market could surpass $50 billion by 2030. That growth outlook keeps Canadian operators relevant for global investors. Recently, renewed federal reform discussions returned to headlines. Cannabis rescheduling remains under active government review. Additionally, lawmakers continue debating banking access and tax reform measures. While timing remains uncertain, momentum has improved compared …
Read More
Trump Expected to Label Pot a Less Dangerous Drug
Published: December 12, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
President Donald Trump is expected have his administration classify marijuana as a less dangerous drug, according to people familiar with the matter. This has been good news for pot stocks.
Read More
Trump Lights Up the Cannabis Market With Plans for Reclassification
Published: December 12, 2025 by: 24/7 Wall Street
Sentiment: Positive
Trump plans to sign an executive order directing federal agencies to reclassify marijuana from Schedule I to Schedule III. Reclassification could boost after-tax profits by 40% to 70% for U.S. cannabis operators by ending the 280E tax penalty.
Read More
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
Published: December 12, 2025 by: CNBC Television
Sentiment: Positive
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.
Read More
Cannabis stocks rise on reports Trump may reschedule marijuana
Published: December 12, 2025 by: Proactive Investors
Sentiment: Positive
Cannabis stocks surged on Friday on reports that President Donald Trump is considering an executive order to reschedule marijuana at the federal level, potentially moving it from Schedule I to Schedule III. According to people familiar with the matter, Trump has discussed the proposal with marijuana industry executives, Health and Human Services Secretary Robert F.
Read More
3 Canadian Marijuana Stocks To Watch In 2026 That Could See A Massive Run
Published: December 10, 2025 by: MarijuanaStocks
Sentiment: Positive
With 2026 showing to be a big year for reform, how will this impact marijuana stocks? Looking back over the years, it is clear that marijuana stocks have seen their best trading when positive news on reform is released. The speculation of what could happen drives the market action up often. If investors feel the reform is important enough, you'll then see some increased buying action.
Read More
3 Of The Best Marijuana Stocks To Buy For Possible Gains In 2026
Published: November 14, 2025 by: MarijuanaStocks
Sentiment: Positive
The big question for marijuana stock investors is how the market will react to the newly passed bill to reverse the 2018 Farm Bill. A new bill was recently passed with language that essentially overturned the Hemp laws in the USA. Many legal operators produced hemp and CBD products to ensure compliance under the bill as a way to energetically take part in the industry. Now, legal operators in legal states cultivating cannabis vs hemp have an entirely different legal road map to follow. Yet this is what many are calling a step backwards, and rightfully so.
Read More
Aurora Cannabis Inc. (ACB:CA) Q2 2026 Earnings Call Transcript
Published: November 05, 2025 by: Seeking Alpha
Sentiment: Neutral
Aurora Cannabis Inc. ( ACB:CA ) Q2 2026 Earnings Call November 5, 2025 8:00 AM EST Company Participants Simona King - Chief Financial Officer Miguel Martin - CEO & Executive Chairman Conference Call Participants William Kirk - ROTH Capital Partners, LLC, Research Division Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Derek Lessard - TD Cowen, Research Division Pablo Zuanic - Zuanic & Associates Presentation Operator Greetings, and welcome to Aurora Cannabis Inc. Fiscal Second Quarter 2026 Results Conference Call. [Operator Instructions] The conference is being recorded today, Wednesday, November 5, 2025.
Read More
Aurora Cannabis Q2 revenue tops estimates on higher medical cannabis sales
Published: November 05, 2025 by: Proactive Investors
Sentiment: Positive
Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) on Wednesday reported second quarter fiscal 2026 net revenue that rose 11% year over year to C$90.4 million, boosted by a 15% increase in medical cannabis sales. Analysts, on average, were expecting revenue of C$87.33 million.
Read More
Aurora Cannabis Inc. (ACB) Tops Q2 Earnings and Revenue Estimates
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago.
Read More
Top Canadian Cannabis Stocks to Watch in November 2025
Published: November 04, 2025 by: MarijuanaStocks
Sentiment: Positive
The Canadian cannabis market continues to evolve as global demand expands and U.S. legalization remains a hot topic. Investors are watching closely as several major producers position themselves for renewed growth through product diversification and strategic international expansion. Despite a challenging regulatory and pricing environment, many companies are shifting focus toward profitability, cost reduction, and high-margin opportunities such as medical exports and branded products.
Read More
Cannabis Investing 2025: 3 Pot Stocks to Watch Before November
Published: October 28, 2025 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry continues to evolve as investors prepare for potential U.S. federal reform and international market expansion. Despite short-term volatility, global demand for both medical and recreational cannabis is increasing. Analysts project the U.S. cannabis market could exceed $50 billion by 2030, driven by growing legalization efforts and shifting consumer attitudes. However, navigating this emerging sector requires careful attention to fundamentals, technical analysis, and disciplined risk management. Traders should focus on companies that show financial stability, market expansion, and consistent revenue growth before the next wave of legalization news.
Read More
How to Play Aurora Cannabis Stock Amid Renewed Legalization Hopes?
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
Aurora Cannabis gains 21% as its medical segment fuels revenue and margin growth, even as recreational sales drag.
Read More
Wall Street Breakfast Podcast: Weed Stocks Light Up
Published: September 30, 2025 by: Seeking Alpha
Sentiment: Positive
Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double digits, with related ETFs MSOS and MJ also posting significant gains.
Read More
Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD
Published: September 29, 2025 by: New York Post
Sentiment: Positive
Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.
Read More
Best Cannabis Stocks in Canada to Watch Now: Technical Signals and Market Outlook
Published: September 18, 2025 by: MarijuanaStocks
Sentiment: Positive
The Canadian cannabis sector remains a focus for investors as September trading continues. Market leaders are working to expand operations while positioning for long-term growth. Meanwhile, the U.S. cannabis industry has surpassed $33 billion in annual sales, with forecasts expecting over $50 billion by 2030. These numbers highlight the global opportunity for Canadian companies with cross-border strategies. Recently, headlines reported new momentum in U.S. legalization talks. Lawmakers are debating the rescheduling of cannabis at the federal level, which could expand banking access and reduce tax burdens. This development has fueled optimism for both U.S. operators and Canadian firms with American …
Read More
About Aurora Cannabis Inc. (ACB)
- IPO Date 2014-07-15
- Website https://www.auroramj.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Miguel Martin
- Employees 1073